Holen Sie sich die Stockscreener-App
9.785
0.15%
-0.015
Handel nachbörslich:
9.90
0.115
+1.18%
Finanzdaten der Transcode Therapeutics Inc-Aktie (RNAZ)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-06-30 | 2024-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
8.06%
4.5612
|
4.2211 | 3.1712 | 5.1139 | 3.289 |
| Operating Income/Loss |
8.06%
-4.5612
|
-4.2211 | -3.1712 | -5.1139 | -3.289 |
| Nonoperating Income/Loss |
432.53%
-0.2949
|
-0.0554 | -8.9142 | -0.0769 | -0.0378 |
| Income/Loss From Continuing Operations Before Tax |
13.55%
-4.8561
|
-4.2765 | -12.09 | -5.1908 | -3.3268 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
13.55%
-4.8561
|
-4.2765 | -12.09 | -5.1908 | -3.3268 |
|
Net Income/Loss
|
13.55%
-4.8561
|
-4.2765 | -12.09 | -5.1908 | -3.3268 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.00%
0.8337
|
0.8337 | 4.8233 | 7.0511 | 5.1424 |
| Diluted Average Shares |
0.00%
0.8337
|
0.8337 | 4.8233 | 7.0511 | 5.1424 |
| Basic Earnings Per Share |
13.45%
-5.82
|
-5.13 | -2.51 | -0.74 | -0.65 |
| Diluted Earnings Per Share |
13.45%
-5.82
|
-5.13 | -2.51 | -0.74 | -0.65 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):